GC73375
Aurora Kinases-IN-3
Also known as 3-[[3-(2-methoxy-4-pyridinyl)-2-pyridinyl]oxy]-N-methyl-5-(trifluoromethoxy)benzamide
Aurora Kinases-IN-3 (Compound 15a) is an orally active AURKB inhibitor that elicits an AURKB-suppressive activity by disrupting the mitotic localization of AURKB
ChemicalCAS2840558-83-8MW419.35FormulaC20H16F3N3O4
- CAS number
- 2840558-83-8
- Molecular weight
- 419.35
- Formula
- C20H16F3N3O4
- Solubility
- DMSO ： 100 mg/mL (238·46 mM; Need ultrasonic)
- InChIKey
- NVMJCTQSUKIXBG-UHFFFAOYSA-N
- Catalogue number
- GC73375
- Brand
- GLPBIO
Computed properties PubChem CID 166176934 · XLogP 4 · TPSA 82.6 Ų · H-bond donors 1
- XLogP
- 4
- TPSA
- 82.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 9
- Rotatable bonds
- 6
- Heavy atoms
- 30
SMILES CNC(=O)C1=CC(=CC(=C1)OC(F)(F)F)OC2=C(C=CC=N2)C3=CC(=NC=C3)OC
Computed descriptors from PubChem (CID 166176934), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il